InvestorsHub Logo
Followers 1
Posts 50
Boards Moderated 0
Alias Born 03/09/2017

Re: Gigi70 post# 2228

Friday, 03/31/2017 9:49:29 AM

Friday, March 31, 2017 9:49:29 AM

Post# of 2536
Good job. Read the part that I put in quotation marks. It's in latter stages of development. It's possible they drop pr about the change in billing to help their products sell better then BOOM drop one on Monday about test being a success. That could make it run like a marathon!!
The review that led to the change in the pricing and billing structure for BREVAGenplus has also sharpened the Company's strategy with respect to other areas of its business. For example, the billing model designed for BREVAGenplus "can also be applicable to the Company's colorectal cancer (CRC) risk assessment test which is in the latter stages of development".
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GENE News